Hospitals are the dominating end-use segment. This leadership is attributed to their high procurement capacity, the integration of handheld devices into multidisciplinary workflows (such as emergency departments and surgical units), and the need for versatile point-of-care tools for rapid triage and guided interventions.
The two spearheading applications are Trauma and Urology. In trauma care, devices are used for rapid FAST tests to detect internal bleeding or organ damage. In urology, they are increasingly indispensable for non-invasive bladder volume assessments, kidney imaging, and prostate monitoring.
AI is being integrated to enhance diagnostic precision, provide automated interpretation, and reduce operator dependency. Recent developments include Butterfly Network’s AI-enhanced software for urology and emergency imaging, which helps clinicians make more accurate assessments regardless of their level of expertise.
Asia-Pacific is identified as the fastest-growing region. This growth is fueled by rapid healthcare infrastructure expansion in China, India, and Southeast Asia, alongside government initiatives focused on rural healthcare and mobile medical services.
Handheld ultrasound devices act as a bridge to close diagnostic access gaps in under-resourced areas. Due to their affordability and portability, they are being deployed by governments and NGOs in rural clinics and mobile units to provide essential imaging services where high-end cart-based systems are unavailable.
The industry is grappling with global semiconductor shortages, logistics interruptions, and strict regulatory compliance hurdles. These factors have sporadically delayed production and commercialization, forcing players to diversify manufacturing bases and accelerate regulatory clearance processes.
Cloud-enabled connectivity allows for seamless teleconsultation and multidisciplinary collaboration. For example, Samsung Medison’s recent launch supports direct cloud connectivity, enabling primary care providers to share images with specialists remotely, thereby improving patient-centric care.
North America leads due to its well-established hospital networks, high penetration of advanced diagnostic equipment, and strong presence of key industry players like GE HealthCare and Philips. Additionally, the region benefits from regulatory incentives that favor point-of-care technology integration.
Despite the benefits, adoption is hindered by reimbursement gaps, a lack of trained personnel to operate the devices, and concerns regarding image resolution when compared to traditional, high-end cart-based ultrasound systems.
